Core Viewpoint - Elon Musk publicly released a drug test report to counter allegations from The New York Times regarding his alleged drug use during the 2024 election period, specifically the use of ketamine and other illicit substances [1][5]. Group 1: Drug Test Results - The drug test conducted by Fastest Labs of South Austin on June 13 showed negative results for all tested substances, including ketamine, ecstasy, marijuana, cocaine, and fentanyl [3][6]. - The report indicated that the urine sample could only detect drug use within the past three days, which does not provide evidence against the allegations of drug use during the election period [6]. Group 2: Allegations and Response - The controversy originated from a May article by The New York Times, which claimed Musk frequently used ketamine and other drugs, carrying a daily medication kit with about 20 substances, including Adderall [4][5]. - Musk firmly denied the allegations, stating he had only used prescription ketamine years ago and criticized the media's motives for the report [5][6]. Group 3: Market Reaction - Following the release of the drug test report, Tesla's stock price fell by 3.88%, resulting in a market capitalization loss of approximately $41 billion [9].